EMA
approval
· 2018-09-21
New gene therapy for rare inherited disorder causing vision loss recommended for approval
Summary
The EMA recommends approval of a new gene therapy intended to treat a rare inherited disorder that causes vision loss.
Upgrade for the full analysis, importance score, and drug timeline.